Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline

Manuela Pinheiro1, Carla Pinto1, Ana Peixoto1

  • 1Department of Genetics, Portuguese Oncology Institute, Rua Doutor António Bernardino Almeida, 4200-072 Porto, Portugal.

Abstract

Insights

Genetic mutations in colorectal cancer (CRC) differ based on tumor location and whether it is Lynch syndrome or sporadic mismatch repair (MMR)-deficient. These findings suggest varied pathways in CRC development, even with MSI.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Sporadic mismatch repair (MMR)-deficient colorectal carcinomas (CRCs) exhibit distinct target gene mutations in the distal colon.
  • Microsatellite instability (MSI) is a key feature in certain colorectal cancers.

Purpose of the Study:

  • To compare target gene mutational patterns in MSI CRC from Lynch syndrome patients.
  • To stratify Lynch syndrome CRC by tumor location and germline mutation.
  • To compare Lynch syndrome CRC with sporadic MSI CRC.

Main Methods:

  • Analysis of MSI in a series of colorectal cancer (CRC) cases from Lynch syndrome patients.
  • Focus on genes involved in colorectal carcinogenesis pathways and selective MSI targets.

Main Results:

  • TGF-β superfamily pathway genes (ACVR2A, TGFBR2) were most frequently mutated.
  • Higher mutation frequencies in CRC with germline MLH1 or MSH2 mutations compared to MSH6.
  • Distal CRC showed more frequent mutations in BMPR2 and MSH3 microsatellite sequences.
  • Differences in MSH3 and TGFBR2 mutation frequency were noted between Lynch syndrome and sporadic MSI CRC based on tumor location.

Conclusions:

  • Genetic alteration patterns in CRC vary by tumor location.
  • Distinct genetic profiles exist between Lynch syndrome and sporadic MSI CRC.
  • Generalised MSI can drive colorectal carcinogenesis through different molecular pathways.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.1K